Skip to content

Market Newsdesk

Latest Business News in Real Time

Posted on November 12, 2020 9:37 am by Newsdesk

SFL – Third Quarter 2020 Results Presentation

Please find enclosed the presentation of the preliminary third quarter results to be held November 12, 2020, in the link below.

Attachment

  • SFL – Third Quarter 2020 Results Presentation

Post navigation

Previous PostPrevious Uncommon Giving Adds Workplace Generosity for Corporate Employee Engagement
Next PostNext InvestorBrandNetwork Named as Official Media Partner for the Benzinga Global Small Cap Conference, InvestorWire to Serve as Official Newswire

Recent Articles

  • Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of April 30, 2026 May 1, 2026 5:58 pm
  • Extreme Networks Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Extreme Networks, Inc. – EXTR May 1, 2026 5:54 pm
  • Soleno Therapeutics 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Soleno Therapeutics, Inc. – SLNO May 1, 2026 5:50 pm
  • DigitalBridge Prices $300 Million Financing Facility, to Repay Outstanding Series 2021-1 Notes May 1, 2026 5:48 pm
  • Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 1, 2026 5:33 pm
  • Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease May 1, 2026 5:31 pm
  • ComEd Reconciliation Filing to Match Cost with Revenues for 2025 and Would Lead to Lower Monthly Bills for Customers May 1, 2026 5:19 pm
  • Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer May 1, 2026 5:08 pm
  • Celcuity’s Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort May 1, 2026 5:06 pm
  • Trident Announces Receipt of Nasdaq Determination Letter and Intent to Request Hearing May 1, 2026 5:03 pm
Proudly powered by WordPress